Renal handling of matrix Gla-protein in humans with moderate to severe hypertension
- PMID: 18971553
- DOI: 10.1291/hypres.31.1745
Renal handling of matrix Gla-protein in humans with moderate to severe hypertension
Abstract
Vascular calcifications are common among patients with hypertension. The vitamin K-dependent protein matrix Gla-protein plays an important role in preventing arterial calcification. Since a decrease in renal clearance is a prevalent clinical problem in patients with hypertension, we aimed to study the renal clearance of matrix Gla-protein from the circulation in these patients having a wide range of creatinine clearances. Ninety moderate to severe hypertensive patients who were scheduled for renal angiography were enrolled in the study. In these patients, renal arterial and renal venous blood was sampled prior to the administration of contrast material in order to determine the total renal and single kidney clearance of matrix Gla-protein. The average renal fractional extraction of matrix Gla-protein was 12.8%. There was no significant correlation between creatinine clearance (range 26-154) and renal fractional extraction of matrix Gla-protein in this population. The extraction of matrix Gla-protein was not influenced by the presence of a renal artery stenosis. In conclusion, we demonstrate that the kidney is able to extract matrix Gla-protein from the plasma at a constant level of 12.8%, independent of renal function in hypertensive subjects.
Similar articles
-
The circulating inactive form of matrix Gla Protein (ucMGP) as a biomarker for cardiovascular calcification.J Vasc Res. 2008;45(5):427-36. doi: 10.1159/000124863. Epub 2008 Apr 10. J Vasc Res. 2008. PMID: 18401181
-
Calcium scores and matrix Gla protein levels: association with vitamin K status.Eur J Clin Invest. 2010 Apr;40(4):344-9. doi: 10.1111/j.1365-2362.2010.02275.x. Eur J Clin Invest. 2010. PMID: 20486996
-
Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.Arterioscler Thromb Vasc Biol. 2005 Aug;25(8):1629-33. doi: 10.1161/01.ATV.0000173313.46222.43. Epub 2005 Jun 16. Arterioscler Thromb Vasc Biol. 2005. PMID: 15961706
-
Molecular mechanisms mediating vascular calcification: role of matrix Gla protein.Nephrology (Carlton). 2006 Oct;11(5):455-61. doi: 10.1111/j.1440-1797.2006.00660.x. Nephrology (Carlton). 2006. PMID: 17014561 Review.
-
[Calcified coronary artery disease and serum markers].Clin Calcium. 2007 Mar;17(3):340-5. Clin Calcium. 2007. PMID: 17339737 Review. Japanese.
Cited by
-
Urinary matrix Gla protein is associated with mortality risk in Flemish population: A prospective study.Front Cardiovasc Med. 2022 Jul 22;9:894447. doi: 10.3389/fcvm.2022.894447. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35935627 Free PMC article.
-
Association of the Inactive Circulating Matrix Gla Protein with Vitamin K Intake, Calcification, Mortality, and Cardiovascular Disease: A Review.Int J Mol Sci. 2019 Feb 1;20(3):628. doi: 10.3390/ijms20030628. Int J Mol Sci. 2019. PMID: 30717170 Free PMC article. Review.
-
Reply to Janssen et al. Comment on "Kremer et al. Kidney Function-Dependence of Vitamin K-Status Parameters: Results from the TransplantLines Biobank and Cohort Studies. Nutrients 2021, 13, 3069".Nutrients. 2022 Jun 13;14(12):2440. doi: 10.3390/nu14122440. Nutrients. 2022. PMID: 35745170 Free PMC article.
-
The Pleiotropic Role of Vitamin K in Multimorbidity of Chronic Obstructive Pulmonary Disease.J Clin Med. 2023 Feb 5;12(4):1261. doi: 10.3390/jcm12041261. J Clin Med. 2023. PMID: 36835797 Free PMC article. Review.
-
Vitamin K effects in human health: new insights beyond bone and cardiovascular health.J Nephrol. 2020 Apr;33(2):239-249. doi: 10.1007/s40620-019-00685-0. Epub 2019 Dec 19. J Nephrol. 2020. PMID: 31858448 Review.